# EDGAR Filing Document

**Accession Number:** 0002029916
**File Stem:** 0001493152-26-010168
**Filing Date:** 2026-3
**Character Count:** 7693
**Document Hash:** 3091966fad220e4cdd4968e0e3821c77
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-010168.hdr.sgml**: 20260316

**ACCESSION NUMBER**: 0001493152-26-010168

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260316

**FILED AS OF DATE**: 20260316

**DATE AS OF CHANGE**: 20260316

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Liu Yanjun Jayla
- **CENTRAL INDEX KEY:** 0002029916

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41801
- **FILM NUMBER:** 26754377

**MAIL ADDRESS:**
- **STREET 1:** 8TH FLOOR, HESHENG WEALTH PLAZA
- **STREET 2:** DESHENGMENWAI STREET
- **CITY:** BEIJING
- **STATE:** F4
- **ZIP:** 100088
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cheche Group Inc.
- **CENTRAL INDEX KEY:** 0001965473
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000

**BUSINESS ADDRESS:**
- **STREET 1:** 8TH FLOOR, DESHENG HESHENG FORTUNE PLAZA
- **STREET 2:** 13-1 DESHENGMENWAI AVENUE, XICHENG DIST.
- **CITY:** BEIJING
- **STATE:** F4
- **ZIP:** 100088
- **BUSINESS PHONE:** 86-105-083-0911

**MAIL ADDRESS:**
- **STREET 1:** 8TH FLOOR, DESHENG HESHENG FORTUNE PLAZA
- **STREET 2:** 13-1 DESHENGMENWAI AVENUE, XICHENG DIST.
- **CITY:** BEIJING
- **STATE:** F4
- **ZIP:** 100088

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Liu Yanjun Jayla<br><sub>(Last) (First) (Middle)</sub><br>8/F, DESHENG HOPSON FORTUNE PLAZA, 13-1<br>DESHENGMENWAI AVENUE, XICHENG DISTRICT<br><sub>(Street)</sub><br>BEIJING, F4 100088<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Cheche Group Inc. [ CCG ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-16 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Operating Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 27326 | D |  |
| Restricted Stock | 8814<sup>(1)</sup> | D |  |
| Restricted Stock | 9401<sup>(2)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option | <sup>(3)</sup> | 2033-12-31 | Class A Common Stock | 36800 | $0.10 | D |  |
| Stock Option | <sup>(4)</sup> | 2034-03-01 | Class A Common Stock | 350 | $0.10 | D |  |
| Stock Option | <sup>(5)</sup> | 2034-06-30 | Class A Common Stock | 20000 | $0.10 | D |  |
| Stock Option | <sup>(6)</sup> | 2035-03-31 | Class A Common Stock | 1000 | $0.10 | D |  |
| Stock Option | <sup>(7)</sup> | 2035-03-31 | Class A Common Stock | 10000 | $0.10 | D |  |

---

### Footnotes:

(1) On April 1, 2021, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted the restricted stock. As of the reporting date, all of the restricted stock has fully vested, but remains subject to transfer restrictions. Such restrictions will lapse, and the shares will become transferable upon the date that is 30 months following the Issuer's initial public offering date ("IPO" date).

(2) On January 1, 2023, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted the restricted stock. All of the restricted stock was fully vested upon grant, but remains subject to transfer restrictions. Such restrictions will lapse, and the shares will become transferable upon the date that is 30 months following the Issuer's IPO date.

(3) On December 31, 2023, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 36,800 shares of the Issuer's common stock. The options vest in equal annual installments over a four-year period, with the first vesting date on December 31, 2024. These options become exercisable upon vesting. Any unvested portion of the options will be forfeited upon the Reporting Person's termination of service.

(4) On March 1, 2024, pursuant to the 2019 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 350 shares of the Issuer's common stock. All of the options were fully vested upon grant. The options become exercisable in installments of 30%, 30%, and 40% upon the dates that are six months, eighteen months, and thirty months, respectively, following the grant date.

(5) On June 30, 2024, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 20,000 shares of the Issuer's common stock. As of the reporting date, all options are vested and exercisable.

(6) On March 31, 2025, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 1,000 shares of the Issuer's common stock. All of the options were fully vested upon grant. The options become exercisable in installments of 30%, 30%, and 40% upon the dates that are six months, eighteen months, and thirty months, respectively, following the grant date.

(7) On March 31, 2025, pursuant to the 2023 Equity Incentive Plan, the Reporting Person was granted stock options to purchase a total of 10,000 shares of the Issuer's common stock. The options vest in equal annual installments over a two-year period, with the first vesting date on March 31, 2026. The vesting will be performance-based, with vesting percentages of 0%, 50%, and 100%, respectively. These options become exercisable upon vesting. Any unvested portion of the options will be forfeited upon the Reporting Person's termination of service.

**Signature:** /s/ Yanjun Jayla Liu  
**Date:** 2026-03-16

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**